“In a recent investigation, a high prevalence of schistosomiasis and strongyloidiasis was found among the Lost Boys and Girls of Sudan. To prevent future morbidity from these diseases, the Centers for Disease Control and Prevention (CDC) recommends that Sudanese refugees should receive pre-departure presumptive treatment for schistosomiasis and strongyloidiasis. Additionally, all members of the Lost Boys and Girls of Sudan and other Sudanese refugees from similar circumstances who have resettled to the U.S. should receive presumptive treatment for schistosomiasis and strongyloidiasis. The regimens for presumptive treatment are the same whether they are given overseas or after arrival to the U.S. …. Treatment for schistosomiasis should consist of praziquantel (Biltricide??) at a dose of 20 mg/kg, given in two oral doses 6-8 hours apart for refugees at least 4 years of age. For Lost Boys and Girls and other Sudanese refugees from similar overseas circumstances who are at least 1 year of age, treatment of strongyloidiasis should consist of albendazole (Albenza??) at a dose of 400 mg, given in oral doses, twice a day for 7 days. This document provides background information on the investigation, rationale for the recommendations, and technical information for physicians.” – Publisher’s description
